Replies to post #210176 on Amarin Corp Plc (AMRN)

[alwayswatching1]

That is a great idea. With Dr. Bhatt and a handful of patient success stories I think the fda will be hard pressed to deny label expansion. The MO thing is still the damn wild card though. Hopefully Bhatt refutes any negative focus derived by the fda. Anyone here thinking ANCHOR indication gets the nod before RI does??